Skip to content

PHARMATRUST: what changed

BE 0696.779.308NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€138,857
2024 · €54,689+€84,168
Equity
€401,657
2024 · €262,800+€138,857
Cash
€97,684
2024 · €79,102+€18,582
Balance sheet total
€716,875
2024 · €539,662+€177,213

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€178,566

    up €178,566 (+62.6%), from €285,381 to €463,947

    of which Trade receivables: +€193,821

  • Cash +€18,582

    up €18,582 (+23.5%), from €79,102 to €97,684

    mainly Net result for the year (+€138,857) and Tax, wage and social debts (+€55,453)

  • Stocks and contracts -€15,362

    down €15,362 (-10.7%), from €144,068 to €128,705

Equity and liabilities
  • Profit (loss) carried forward +€138,857

    up €138,857 (+54.5%), from €254,740 to €393,597

  • Tax, wage and social debts +€55,453

    up €55,453 (+203%), from €27,266 to €82,719

    of which Taxes: +€54,947

  • Other debts -€24,212

    down €24,212 (-48.2%), from €50,252 to €26,039

  • Trade debts +€7,520

    up €7,520 (+3.8%), from €198,939 to €206,459

Income statement
  • Gross operating margin +€112,466

    up €112,466 (+72.3%), from €155,452 to €267,918

  • Taxes +€30,655

    up €30,655 (+154%), from €19,908 to €50,562

  • Staff costs -€4,724

    down €4,724 (-6.7%), from €70,939 to €66,214

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €54,689
Gross operating margin +€112,466
Staff costs +€4,724
Depreciation -€390
Other operating charges -€1,702
Financial income +€3
Financial charges -€279
Taxes -€30,655
Result 2025 €138,857
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€23,888
Investment -€4,902
Financing -€405
Cash 2024 €79,102
Net result for the year +€138,857
Depreciation +€8,700
Stocks and contracts +€15,362
Receivables within one year -€178,566
Deferred charges and accrued income +€774
Trade debts +€7,520
Tax, wage and social debts +€55,453
Other debts -€24,212
Investment in fixed assets (net) -€4,902
Current portion of long-term debt -€405
Cash 2025 €97,684
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €539,662 €716,875 +€177,213 +32.8%
Fixed assets 21/28 €29,644 €25,845 -€3,798 -12.8%
Intangible fixed assets 21 €15,566 €10,776 -€4,789 -30.8%
Tangible fixed assets 22/27 €14,078 €15,069 +€991 +7.0%
Furniture and vehicles 24 - €1,823 +€1,823
Leasing and similar rights 25 €4,455 €2,335 -€2,120 -47.6%
Other tangible fixed assets 26 €9,623 €10,911 +€1,288 +13.4%
Current assets 29/58 €510,018 €691,029 +€181,011 +35.5%
Stocks and contracts in progress 3 €144,068 €128,705 -€15,362 -10.7%
Stocks 30/36 €144,068 €128,705 -€15,362 -10.7%
Amounts receivable within one year 40/41 €285,381 €463,947 +€178,566 +62.6%
Trade receivables 40 €190,026 €383,846 +€193,821 +102%
Other amounts receivable 41 €95,355 €80,101 -€15,255 -16.0%
Cash at bank and in hand 54/58 €79,102 €97,684 +€18,582 +23.5%
Deferred charges and accrued income 490/1 €1,467 €693 -€774 -52.8%
Total equity and liabilities 10/49 €539,662 €716,875 +€177,213 +32.8%
Equity 10/15 €262,800 €401,657 +€138,857 +52.8%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €0 - =
Reserves not available under the articles 1311 €0 - =
Distributable reserves 133 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €254,740 €393,597 +€138,857 +54.5%
Amounts payable 17/49 €276,861 €315,217 +€38,356 +13.9%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €276,861 €315,217 +€38,356 +13.9%
Current portion of amounts payable after more than one year 42 €405 €0 -€405 -100%
Trade debts 44 €198,939 €206,459 +€7,520 +3.8%
Suppliers 440/4 €198,939 €206,459 +€7,520 +3.8%
Taxes, remuneration and social security 45 €27,266 €82,719 +€55,453 +203%
Taxes 450/3 €16,412 €71,359 +€54,947 +335%
Remuneration and social security 454/9 €10,853 €11,360 +€507 +4.7%
Other amounts payable 47/48 €50,252 €26,039 -€24,212 -48.2%
Accrued charges and deferred income 492/3 €0 - =
Remuneration, social security and pensions 62 €70,939 €66,214 -€4,724 -6.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,310 €8,700 +€390 +4.7%
Other operating charges 640/8 €402 €2,104 +€1,702 +423%
Gross operating margin 9900 €155,452 €267,918 +€112,466 +72.3%
Operating profit (loss) 9901 €75,801 €190,900 +€115,099 +152%
Financial income 75/76B €1 €4 +€3 +220%
Recurring financial income 75 €1 €4 +€3 +220%
Financial charges 65/66B €1,206 €1,484 +€279 +23.1%
Recurring financial charges 65 €1,206 €1,484 +€279 +23.1%
Profit (loss) for the period before taxes 9903 €74,596 €189,419 +€114,823 +154%
Income taxes 67/77 €19,908 €50,562 +€30,655 +154%
Profit (loss) for the period 9904 €54,689 €138,857 +€84,168 +154%
Profit (loss) for the period to be appropriated 9905 €54,689 €138,857 +€84,168 +154%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€441,234 to €539,551

Midpoint €482,199 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €390,881
Capitalised earnings €491,586 to €688,220
Indication €441,234 to €539,551

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€401,657
Intangible fixed assets (21)
-€10,776
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€390,881

Capitalised earnings

net result for the year (9904)
2025
€138,857
2024
€54,689
2023
€12,920
2022
€53,414
excluding non-recurring income and charges
€69,501
2021
€58,472
Average result
€68,822
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€491,586 / €573,517 / €688,220

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.